Pfizer
Thorsten Mintel is an accomplished professional in the pharmaceutical industry with extensive experience spanning over three decades. Currently serving as the Director of Strategic Innovation and Director of Customer + Digital Marketing at Pfizer since December 2010, Thorsten previously held the position of Sales Director at Pfizer from January 1999 to 2010, overseeing various regional and national responsibilities in areas such as cardiovascular, diabetes, COPD, and primary care. Prior to Pfizer, Thorsten worked as a Sales Manager at Schwarz Pharma (now UCB) from 1995 to 1998 and as a District Manager at Astra Zeneca from 1987 to 1995, where initial experience included three years as a sales representative. Thorsten holds a Betriebswirt (BA) degree from Wirtschaftsakademie S-H, earned between 1983 and 1986.
This person is not in any teams
This person is not in any offices
Pfizer
615 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.